CVE:RLV Relevium Technologies (RLV) Stock Price, News & Analysis C$0.02 0.00 (0.00%) (As of 01/7/2022) Add Compare Share Share Stock Analysis Stock Analysis About Relevium Technologies Stock (CVE:RLV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Relevium Technologies alerts:Sign Up Key Stats Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume130,500 shsAverage Volume140,861 shsMarket CapitalizationC$6.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRelevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.Read More… The most serious warning of my career (Ad)With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. Click here now to grab your seat now. Receive RLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relevium Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address RLV Stock News HeadlinesRLLVF Relevium Technologies Inc.October 30 at 2:58 PM | seekingalpha.comRelevium Technologies Inc (RLVh)October 17, 2023 | investing.comBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonOctober 31, 2024 | Porter & Company (Ad)Dru Hill’s Sisqo Responds To Jodeci ‘Verzuz’ Battle DebateAugust 11, 2022 | yahoo.comRelevium Provides Operational and Continued Disclosure UpdateFebruary 11, 2022 | yahoo.comRelevium Provides Bi-Weekly Update to Management Cease Trade OrderJanuary 5, 2022 | finance.yahoo.comRelevium Provides Bi-Weekly Update to Management Cease Trade Order and Shares for Debt SettlementDecember 18, 2021 | financialpost.comRelevium Provides Update to Management Cease Trade Order and Other MattersNovember 19, 2021 | finance.yahoo.comSee More Headlines RLV Stock Analysis - Frequently Asked Questions How have RLV shares performed this year? Relevium Technologies' stock was trading at C$0.02 at the beginning of 2024. Since then, RLV shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. How do I buy shares of Relevium Technologies? Shares of RLV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Relevium Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Relevium Technologies investors own include C-Com Satellite Systems (CMI), Facedrive (FDVRF), Focus Graphite (FMS), Kraken Robotics (PNG), Quisitive Technology Solutions (QUISF), Spero Therapeutics (SPRO) and Tinkerine Studios (TTD). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolCVE:RLV CUSIPN/A CIKN/A Webwww.releviumcorp.com Phone+1-514-8248559FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,640,000.00 Net Margins-18.50% Pretax MarginN/A Return on EquityN/A Return on Assets4.20% Debt Debt-to-Equity Ratio8,068.50 Current Ratio0.60 Quick Ratio0.02 Sales & Book Value Annual SalesC$14.25 million Price / Sales0.46 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares329,490,000Free FloatN/AMarket CapC$6.59 million OptionableNot Optionable Beta1.88 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (CVE:RLV) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relevium Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relevium Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.